Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial
Journal of Integrative and Complementary Medicine · 2024
DOI: 10.1089/jicm.2023.0777 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Integrative and Complementary Medicine, 2024. Verfasst von Azin Alizadehasl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardio-Oncology Research Center, Rajaie Cardiovascular Medical & Research Center, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Anthracyclines, Breast Neoplasms, Cardiotoxicity, Cardiotonic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objectives
Several studies have indicated that dietary interventions may offer protection against the development of cardiac damage in the case of anthracycline-induced cardiomyopathy (AIC). The goal of this study was to assess whether an evidence-based cardioprotective diet can be effective in preventing AIC in patients with breast cancer.
Design
Randomized, open-label, controlled trial. The study period was set for 18 weeks, and the data were analyzed by generalized estimating equation modeling and one-way repeated measures analysis of variance. Setting/Location: Shahid Rajaie Hospital affiliated (Tehran, Iran). Subjects: Fifty anthracycline-treated patients with breast cancer.
Interventions
Patients were randomized to receive either a 2-hour training in evidence-based cardio-protective diet or Carvedilol 6.25 mg bid. Outcome Measures: The primary outcome was the number of patients with abnormal left ventricular ejection fraction (LVEF) after 18 weeks.
Results
At week 18, 12 (48%) out of 25 participants in the cardioprotective diet group had abnormal LVEF in comparison with 21 (84%) out of 25 in the carvedilol group ( p = 0.007). Also, 2 (8%) out of 25 in the cardioprotective diet group compared with 7 (28%) out of 25 participants in the carvedilol group had abnormal global longitudinal strain ( p = 0.066). The diet group showed significant improvements in the quality-of-life dimensions named “health change” and “general health” compared with the carvedilol group using the Short Form-36 Health Survey questionnaire.
Conclusions
This study suggests that an evidence-based cardioprotective diet can contribute to the prevention of AIC. Although current treatments for AIC can be effective, further research is mandatory for more options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardio-Oncology Research Center, Rajaie Cardiovascular Medical & Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Shohada-e Tajrish Hospital, Department of RadioOncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Cancer Research Center, Shohadae Tajrish Hospital, Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Clinical Research Development Center, Mahdiyeh Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Institute for General Practice and Interprofessional Care, Tuebingen, University Hospital Tuebingen, Tuebingen, Germany.
ORCID-Profile: Holger Cramer, Mehdi Pasalar, Ghazaleh Heydarirad
Zitieren
APA
Alizadehasl, A., Malekzadeh Moghani, M., Mirzaei, H., Keshvari, M., Fadaei, F., Cramer, H., Pasalar, M., & Heydarirad, G. (2024). Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial. Journal of Integrative and Complementary Medicine. https://doi.org/10.1089/jicm.2023.0777
Vancouver
Alizadehasl A, Malekzadeh Moghani M, Mirzaei H, Keshvari M, Fadaei F, Cramer H, et al. Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial. Journal of Integrative and Complementary Medicine. 2024. doi:10.1089/jicm.2023.0777
BibTeX
@article{Alizadehasl2024,
author = {Alizadehasl, Azin and Malekzadeh Moghani, Mona and Mirzaei, Hamidreza and Keshvari, Masoumeh and Fadaei, Fatemeh and Cramer, Holger and Pasalar, Mehdi and Heydarirad, Ghazaleh},
title = {Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial},
journal = {Journal of Integrative and Complementary Medicine},
year = {2024},
doi = {10.1089/jicm.2023.0777}
}
EUVIMED